Human Brain Project Addresses Detractors

Officials behind the European brain mapping effort take preliminary steps to tackle concerns voiced about the project.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, WYGLIFAfter hundreds of neuroscientists signed an open letter criticizing the governance and goals of the European Commission’s (EC) Human Brain Project (HBP), leaders of the initiative have met with the letter’s organizers to address some of the concerns, according to Nature. Citing an unnamed and “cautious source,” Nature said that HBP officials met with some of the researchers who signed the letter last Thursday (July 10) to engage in “the beginnings of discussions of some of the issues.”

The July 7 letter, which has now garnered more than 650 signatures, complained of a lack of transparency in how the HBP is being managed, an overly ambitious and misplaced goal of building a computer simulation of the human brain, and a lack of funding for conventional cognitive research that deals with high-level brain functions such as thought, consciousness, and behavior. Signatories of the letter, key European neuroscientists among them, threaten not to apply for any of the HBP €1.2 billion ($1.6 billion) in research funding.

As signatures began accumulating on the letter last week, HBP leadership and the EC first downplayed the concerns, with EC officials saying in a statement to Nature on Thursday that it was “too early to draw conclusions on the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies